Active substance: Carbetocin Indications for use, specifying the target species Cow: - Uterine atony during the puerperal period - Placental retention as a consequence of uterine atony - Initiation of milk ejection in stress-induced agalactia or in conditions requiring udder emptying Sow: Acceleration or restart of parturition after disruption of uterine contractions (uterine atony or inertia) following the expulsion of at least 1 piglet -Supportive therapy of mastitis-metritis-agalactia (MMA-) syndrome -Initiation of milk ejection -Shortening of total parturition duration as a component of synchronisation of parturition in sows. The product may be applied to sows which have previously been administered an appropriate PGF2(e.g. cloprostenol) not prior to day 114 of pregnancy and have not started farrowing within 24 hours after the PGF2 injection (day 1 of pregnancy is the last day of insemination)
